WBB Securities Sponsors BioCentury’s Annual NewsMakers Conference
Posted: Sep 7th, 2018In: Press ReleasesWBB Securities is a sponsor of this year’s NewsMakers in the Biotech Industry conference.
Read More about WBB Securities Sponsors BioCentury’s Annual NewsMakers ConferenceWBB Securities Acts as Co-Manager in $52 Million Follow-on Financing for T2 Biosystems
Posted: Jun 5th, 2018In: Press ReleasesWBB Securities acted as co-manager to a transaction for T2 Biosystems, Inc., a manufacturer of next generation, rapid diagnostic equipment.
Read More about WBB Securities Acts as Co-Manager in $52 Million Follow-on Financing for T2 BiosystemsWBB Securities Sponsors BioCentury’s 2018 Future Leaders Conference
Posted: Mar 23rd, 2018In: Press ReleasesWBB Securities is a sponsor of this year’s Future Leader’s conference.
Read More about WBB Securities Sponsors BioCentury’s 2018 Future Leaders ConferenceWBB Securities Asset Management Receives Hedgeweek Award For Life Sciences Investing
Posted: Sep 22nd, 2017In: Press ReleasesWBB Securities, LLC is pleased to announce that the WBB Asset Management Long/Short Life Science Strategy (LSLSS) was the recipient of Hedgeweek USA’s 2017 Award for Best Event Driven Strategy last night in New York[...]
Read More about WBB Securities Asset Management Receives Hedgeweek Award For Life Sciences InvestingWBB Securities Acts as Co-Manager in $17 Million Follow-on Financing for T2 Biosystems
Posted: Sep 21st, 2017In: Press ReleasesWBB Securities acted as co-manager to a transaction for T2 Biosystems, Inc., a manufacturer of next generation, rapid diagnostic equipment.
Read More about WBB Securities Acts as Co-Manager in $17 Million Follow-on Financing for T2 BiosystemsWBB Securities Sponsors BioCentury’s Annual NewsMakers Conference
Posted: Sep 8th, 2017In: Press ReleasesWBB Securities is a sponsor of this year’s NewsMakers in the Biotech Industry conference.
Read More about WBB Securities Sponsors BioCentury’s Annual NewsMakers ConferenceWBB Securities Acts as Co-Manager in $40 Million Follow-on Financing for Corium International, Inc.
Posted: May 31st, 2017In: Press ReleasesWBB Securities acted as co-manager to a transaction for Corium International, Inc., a commercial stage developer of transdermal healthcare products.
Read More about WBB Securities Acts as Co-Manager in $40 Million Follow-on Financing for Corium International, Inc.WBB Securities Sponsors BioCentury’s 2017 Future Leaders Conference
Posted: Apr 7th, 2017In: Press ReleasesWBB Securities is a sponsor of this year’s Future Leader’s conference.
Read More about WBB Securities Sponsors BioCentury’s 2017 Future Leaders ConferenceWBB Securities Acts as Financial Advisor to T2 Biosystems for $50 Million Credit Facility
Posted: Jan 5th, 2017In: Press ReleasesWBB Securities acted as financial advisor to T2 Biosystems, Inc., a manufacturer of next generation diagnostic equipment, for a credit facility up to $50 million.
Read More about WBB Securities Acts as Financial Advisor to T2 Biosystems for $50 Million Credit FacilityWBB Securities Acts as Co-Manager for $300 Million Public Offering for Sarepta Therapeutics
Posted: Sep 29th, 2016In: Press ReleasesWBB Securities acted as co-manager to a transaction for Sarepta Therapeutics, Inc., a developer of innovative RNA-targeted therapeutics.
Read More about WBB Securities Acts as Co-Manager for $300 Million Public Offering for Sarepta Therapeutics